$1.5299
-0.0001[-0.01%]
Last update: 2:33PM Get Real Time Here
Ocuphire Pharma
(NASDAQ:OCUP)Ocuphire Pharma Stock (NASDAQ:OCUP), Analyst Ratings, Price Targets, Predictions
Ocuphire Pharma Inc has a consensus price target of $20.75, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Alliance Global Partners, HC Wainwright & Co., and HC Wainwright & Co. on March 20, 2024, March 11, 2024, and November 14, 2023. With an average price target of $20 between Alliance Global Partners, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1207.27% upside for Ocuphire Pharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
HC Wainwright & Co.
Cantor Fitzgerald
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Ocuphire Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2024 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | Alliance Global Partners | James Molloy | $24 → $20 | Maintains | Buy | Get Alert |
| 03/11/2024 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1011.18% | Cantor Fitzgerald | Kristen Kluska | → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | → $20 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1207.27% | HC Wainwright & Co. | Matthew Caufield | $26 → $20 | Maintains | Buy | Get Alert |
| 11/24/2021 | OCUP | Buy Now | Ocuphire Pharma | $1.53 | 1599.46% | HC Wainwright & Co. | Andrew Fein | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Ocuphire Pharma (OCUP)?
The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Alliance Global Partners on March 20, 2024. The analyst firm set a price target for $20.00 expecting OCUP to rise to within 12 months (a possible 1207.27% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ocuphire Pharma (OCUP)?
The latest analyst rating for Ocuphire Pharma (NASDAQ: OCUP) was provided by Alliance Global Partners, and Ocuphire Pharma maintained their buy rating.
When was the last upgrade for Ocuphire Pharma (OCUP)?
There is no last upgrade for Ocuphire Pharma.
When was the last downgrade for Ocuphire Pharma (OCUP)?
There is no last downgrade for Ocuphire Pharma.
When is the next analyst rating going to be posted or updated for Ocuphire Pharma (OCUP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocuphire Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocuphire Pharma was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.
Is the Analyst Rating Ocuphire Pharma (OCUP) correct?
While ratings are subjective and will change, the latest Ocuphire Pharma (OCUP) rating was a maintained with a price target of $24.00 to $20.00. The current price Ocuphire Pharma (OCUP) is trading at is $1.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.